Teva To Pay Up To $70M To Settle With Pfizer
Pfizer Inc. and Teva Pharmaceutical Industries Ltd. have agreed to settle pending patent litigation over generic versions of Pfizer's antibiotic Zithromax and its cancer drug Idamycin for up to $70 million,...To view the full article, register now.
Already a subscriber? Click here to view full article